Search research articles
Contact Us
Filters
Showing results (101-110 of 1,071) with videos related to
Page
of 108
Sort By:
Human Genetics
|
February 8, 2003
Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)
Jian Wang, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
December 13, 2016
PCSK9 inhibition and diabetes: turning to Mendel for clues
Jooho Lee, Robert A Hegele
Current Opinion in Endocrinology, Diabetes, and Obesity
|
November 28, 2021
Advances in the care of lipodystrophies
Isabel Shamsudeen, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
Inducing thyrotoxicosis in the liver to treat raised cholesterol
Robina Rana, Robert A Hegele
Expert Review of Cardiovascular Therapy
|
July 15, 2021
Volanesorsen for treatment of familial chylomicronemia syndrome
Julieta Lazarte, Robert A Hegele
The Journal of International Medical Research
|
August 28, 2024
Elderly patients with very high plasma lipoprotein(a) concentrations and few cardiovascular consequences: a case series
Shyann Hang, Robert A Hegele
The Canadian Journal of Cardiology
|
August 21, 2014
Is plant-based cardioprotection evidence-based?
Amanda Brahm, Robert A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 1, 2015
Ezetimibe: rescued by randomization (clinical and mendelian)
Ruth McPherson, Robert A Hegele
European Heart Journal
|
June 24, 2020
Triglyceride-rich particles: new actors in valvular aortic stenosis
Albert Varga, Robert A Hegele
Current Opinion in Lipidology
|
June 11, 2020
Can genetic testing help in the management of dyslipidaemias?
Julieta Lazarte, Robert A Hegele
Page
of 108
Search research articles
Search
Showing results (101-110 of 1,071) with videos related to
Sort By:
Page
of 108
Human Genetics
|
February 8, 2003
Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)
Jian Wang, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
December 13, 2016
PCSK9 inhibition and diabetes: turning to Mendel for clues
Jooho Lee, Robert A Hegele
Current Opinion in Endocrinology, Diabetes, and Obesity
|
November 28, 2021
Advances in the care of lipodystrophies
Isabel Shamsudeen, Robert A Hegele
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
Inducing thyrotoxicosis in the liver to treat raised cholesterol
Robina Rana, Robert A Hegele
Expert Review of Cardiovascular Therapy
|
July 15, 2021
Volanesorsen for treatment of familial chylomicronemia syndrome
Julieta Lazarte, Robert A Hegele
The Journal of International Medical Research
|
August 28, 2024
Elderly patients with very high plasma lipoprotein(a) concentrations and few cardiovascular consequences: a case series
Shyann Hang, Robert A Hegele
The Canadian Journal of Cardiology
|
August 21, 2014
Is plant-based cardioprotection evidence-based?
Amanda Brahm, Robert A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 1, 2015
Ezetimibe: rescued by randomization (clinical and mendelian)
Ruth McPherson, Robert A Hegele
European Heart Journal
|
June 24, 2020
Triglyceride-rich particles: new actors in valvular aortic stenosis
Albert Varga, Robert A Hegele
Current Opinion in Lipidology
|
June 11, 2020
Can genetic testing help in the management of dyslipidaemias?
Julieta Lazarte, Robert A Hegele
Page
of 108